FDA — authorised 10 December 1997
- Marketing authorisation holder: HOFFMAN-LA ROCHE
- Status: approved
🇺🇸 Zenapax in United States
FDA authorised Zenapax on 10 December 1997
Marketing authorisation
Zenapax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Zenapax approved in United States?
Yes. FDA authorised it on 10 December 1997.
Who is the marketing authorisation holder for Zenapax in United States?
HOFFMAN-LA ROCHE holds the US marketing authorisation.